基本信息
views: 211
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Sooryamarayana (Soory) Varambally is a Professor at the Department of Pathology at The University of Alabama at Birmingham. Dr. Varambally's integrative cancer research focuses on understanding the molecular basis of cancer initiation, progression and identification of therapeutic targets. His group investigates cancers using genomics, epigenetics, bioinformatics, discovery/validation of biomarkers, and targeting of key oncogenes. Dr. Varambally contributed to many seminal discoveries including identification of EZH2, a histone methyltransferase as oncogenic in various cancers and recurrent gene fusion ERG in prostate cancer. His transformative efforts toward enhancing the precision targeting in the fight against cancer led to the development and deployment of a comprehensive cancer proteo-genomic data analysis platform, the UALCAN (University of ALabama CANcer data portal, ualcan.path.uab.edu). This public data analysis portal aids in examining “big cancer data” in a user-friendly format, allowing cancer researchers and clinicians to identify biomarkers and precision targets.
Research Interests
Papers共 297 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 6_Supplement (2024): 5973-5973
Prachi Bajpai,Ravi Paluri,Sameer Al Diffalha,Darshan S. Chandrashekar,Farrukh Afaq,Ryan Bash, C. Ryan Miller,Sooryanarayana Varambally,Moh’d Khushman, Upender Manne
Cancer Researchno. 2_Supplement (2024)
CANCER RESEARCHno. 2 (2024)
NEOPLASIA (2024): 100951-100951
Cancer Researchno. 6_Supplement (2024): 585-585
crossref(2023)
The Prostateno. 6 (2023): 590-601
Cancer Researchno. 7_Supplement (2023): 4969-4969
crossref(2023)
Load More
Author Statistics
#Papers: 298
#Citation: 57288
H-Index: 74
G-Index: 182
Sociability: 7
Diversity: 3
Activity: 88
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn